GLENDALE, Calif., July 22 /PRNewswire/ -- Nestle USA Chairman and CEO Brad Alford has announced that Nestle Research Center, based in Lausanne, Switzerland, has donated US $500,000 to Cleveland Clinic's Lerner Research Institute.

Reporting in Nature Cell Biology, researchers describe the discovery of a specific protein called disabled-2 (Dab2) that switches on the process that releases cancer cells from the original tumor and allows the cells to spread and develop into new tumors in other parts of the body.

CLEVELAND, Nov. 10 /PRNewswire/ -- Charis Eng, M.D., Ph.D., Chair and Director of Cleveland Clinic Lerner Research Institute's Genomic Medicine Institute, has been appointed to the U.S.

Alios BioPharma, Inc. and Cleveland Clinic today a

Cleveland BioLabs, Inc. (NASDAQ: CBLI) today annou